Neuralstem Inc (NYSE MKT LLC:CUR)

During the Trading Day
3.79 +0.02 / +0.53%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
3.84 +0.05 / +1.32%
 
Volume: 1.8K
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$331.5M

Company Description

Neuralstem, Inc. is a biopharmaceutical company, which is focused on the development and commercialization of treatments based on human neuronal stem cells and small molecule compounds. It develops biotherapeutic products to treat and cure neurodegenerative and neurological disorders of the brain and spinal cord, including Parkinson's, Alzheimer's, stroke, multiple sclerosis, spinal cord injury and epilepsy. The company was founded by I. Richard Garr, Karl Johe and Merrill Solomon in 1996 and is headquartered in Germantown, MD.

Contact Information

Neuralstem, Inc.
20271 Goldenrod Lane
Germantown Maryland 20876
P:(301) 366-4960
Investor Relations:

Employees

Shareholders

Other institutional9.36%
Individual stakeholders6.26%
Mutual fund holders14.47%

Top Executives

Karl Y. JoheChairman & Chief Scientific Officer
I. Richard GarrPresident, CEO, CFO, Director & Legal Counsel
Thomas HazelSenior Vice President-Research

To view my watchlist

Not a member yet?

Sign up now for a free account